⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET
globenewswire.com
BBIO
Condor Unveils AI-Powered Investigator Grants Intelligence
prnewswire.com
ACAD
BBIO
MDGL
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Form 8-K
sec.gov
BBIO
Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
globenewswire.com
BBIO
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
globenewswire.com
BBIO
MyOme Launches CASRcade, a No Charge Family Cascade Genetic Testing Program for Families Affected by ADH1
prnewswire.com
BBIO
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Nova Scotia Ready to Announce with Confidence?
newsfilecorp.com
BBIO
BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026
globenewswire.com
BBIO
BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting
globenewswire.com
BBIO